Our study here was to investigate the effects of miR-155 on cell proliferation, cell cycle and cell apoptosis of ERalpha (+) breast cancer cells and to verify whether TP53INP1 is a target of miR-155, and tried to explore the mechanisms of miR-155 in this process. Here, ESR1 is linked to breast carcinoma.